Fibrillization of Human Tau Is Accelerated by Exposure to Lead via Interaction with His-330 and His-362
2011

Lead Exposure Accelerates Tau Fibrillization

publication Evidence: moderate

Author Information

Author(s): Zhu Hai-Li, Meng Sheng-Rong, Fan Jun-Bao, Chen Jie, Liang Yi

Primary Institution: State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China

Hypothesis

Does lead (Pb2+) play a role in the pathology of Alzheimer disease through interaction with human Tau protein?

Conclusion

Lead exposure accelerates the fibrillization of human Tau protein, suggesting its involvement in the pathogenesis of Alzheimer disease.

Supporting Evidence

  • Lead exposure significantly accelerates the fibrillization of Tau protein.
  • Fibrils formed in the presence of lead contain more β-sheet structure than those formed without lead.
  • His-330 and His-362 are key residues for the interaction of lead with Tau protein.

Takeaway

When lead is present, it makes a protein called Tau clump together faster, which might be linked to Alzheimer's disease.

Methodology

The study used various biophysical methods including thioflavin T binding assays, circular dichroism, and isothermal titration calorimetry to investigate the effects of lead on Tau fibrillization.

Limitations

The study primarily focused on a specific fragment of Tau and did not explore the effects of lead on full-length Tau protein in detail.

Digital Object Identifier (DOI)

10.1371/journal.pone.0025020

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication